• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Ophthalmology

Anonymous board for Ophthalmology reps
Replies
2
Views
7K
anonymous
Replies
2
Views
8K
anonymous
Replies
7
Views
13K
anonymous
Replies
11
Views
9K
anonymous
Replies
0
Views
2K
anonymous
Replies
12
Views
11K
anonymous
Replies
6
Views
9K
anonymous
Replies
0
Views
3K
Anonymous
Replies
20
Views
13K
Anonymous
Replies
3
Views
5K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
0
Views
4K
Anonymous
PRN
Replies
6
Views
6K
Anonymous
Replies
3
Views
7K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
4
Views
7K
Anonymous
Replies
2
Views
2K
Anonymous
Replies
10
Views
7K
Anonymous
Replies
2
Views
4K
Anonymous